Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 known ✓ | O43570 | 1/20 | 0.40 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.40 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.40 |
| ▸ | P2RY12 known ✓ | Q9H244 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | CASP6 | P55212 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | NT5E | P21589 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29702707 | 1.00 | ALDH1A1 (0.53) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| SCHEMBL8772805 | 0.86 | LMNA (0.47) | ALDH1A1HSD17B10CYP2C9CYP2C19TDP1 | |
| SCHEMBL142003 | 0.86 | ALDH1A1 (0.59) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| SCHEMBL153646 | 0.86 | ALDH1A1 (0.59) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| SCHEMBL342536 | 0.85 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| SCHEMBL29473550 | 0.85 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| SCHEMBL7064778 | 0.84 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL28203178 | 0.84 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| SCHEMBL142001 | 0.84 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 | |
| Water SCHEMBL29627107 | 0.83 | ALDH1A1 (0.56) | ALDH1A1HSD17B10CASP6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10468701-B2 | Multi-acid polymers from multifunctional amino acids and sulfonyl halide precursors and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2019-11-05 | — | — | US | claimed |
| US-20170279145-A1 | MULTI-ACID POLYMERS FROM MULTIFUNCTIONAL AMINO ACIDS AND SULFONYL HALIDE PRECURSORS AND METHODS OF MAKING THE SAME | NISSAN MOTOR CO., LTD. (JP) | 2017-09-28 | — | — | US | claimed |
| CN-113121392-B | Aminobenzene sulfonic acid compound crystal particles and preparation method thereof | 上海合丽亚化工科技有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-113121392-A | Aminobenzene sulfonic acid compound crystal particles and preparation method thereof | 上海合丽亚化工科技有限公司 | 2021-07-16 | — | — | CN | disclosed |
| US-10930961-B2 | Multi-acid polymers from multifunctional amino phosphonic acids and sulfonyl halide precursors and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2021-02-23 | — | — | US | disclosed |
| US-10468701-B2 | Multi-acid polymers from multifunctional amino acids and sulfonyl halide precursors and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2019-11-05 | — | — | US | disclosed |
| US-20190013538-A1 | Multi-Acid Polymers From Multifunctional Amino Acids and Sulfonyl Halide Precursors and Methods of Making the Same | NISSAN MOTOR CO., LTD. (JP) | 2019-01-10 | — | — | US | disclosed |
| US-10153505-B2 | Multi-acid polymers from multifunctional amino acids and sulfonyl halide precursors and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2018-12-11 | — | — | US | disclosed |
| US-10035144-B2 | Multi-acid polymers and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2018-07-31 | — | — | US | disclosed |
| US-9861977-B2 | Multi-acid polymers and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2018-01-09 | — | — | US | disclosed |
| US-20170279144-A1 | MULTI-ACID POLYMERS FROM MULTIFUNCTIONAL AMINO ACIDS AND SULFONYL HALIDE PRECURSORS AND METHODS OF MAKING THE SAME | NISSAN MOTOR CO., LTD. (JP) | 2017-09-28 | — | — | US | disclosed |
| US-20170274369-A1 | Multi-Acid Polymers and Methods of Making the Same | NISSAN MOTOR CO., LTD. (JP) | 2017-09-28 | — | — | US | disclosed |
| US-20170274368-A1 | MULTI-ACID POLYMERS AND METHODS OF MAKING THE SAME | NISSAN MOTOR CO., LTD. (JP) | 2017-09-28 | — | — | US | disclosed |
| US-20170279145-A1 | MULTI-ACID POLYMERS FROM MULTIFUNCTIONAL AMINO ACIDS AND SULFONYL HALIDE PRECURSORS AND METHODS OF MAKING THE SAME | NISSAN MOTOR CO., LTD. (JP) | 2017-09-28 | — | — | US | disclosed |
| US-9694357-B1 | Multi-acid polymers and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2017-07-04 | — | — | US | disclosed |
| US-8679195-B2 | Tanning process and tanning composition | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-03-25 | — | — | US | disclosed |
| EP-2430197-B1 | TANNING PROCESS AND TANNING COMPOSITION | CLARIANT FINANCE BVI LTD (VG) | 2013-01-16 | — | — | EP | disclosed |
| EP-2430197-A1 | TANNING PROCESS AND TANNING COMPOSITION | Clariant Finance (BVI) Limited (VG) | 2012-03-21 | — | — | EP | disclosed |
| US-20120058357-A1 | Tanning Process and Tanning Composition | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-03-08 | — | — | US | disclosed |
| WO-2010130311-A1 | TANNING PROCESS AND TANNING COMPOSITION | CLARIANT INTERNATIONAL LTD (CH) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170274368-A1 | MULTI-ACID POLYMERS AND METHODS OF MAKING THE SAME | FRS2, FXR2, PFAS | CA12 777/4885CA1 2184/4885CA2 595/4885 |
| US-10035144-B2 | Multi-acid polymers and methods of making the same | INSR, IAPP, SLC5A6 | CA12 571/4885CA1 387/4885CA2 72/4885 |
| US-20170274369-A1 | Multi-Acid Polymers and Methods of Making the Same | FRS2, PFAS, SOS2 | CA12 1096/4885CA1 2101/4885CA2 587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.